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Intracerebral Granulocytic Sarcoma in
recurrence of Chronic Myeloid Leukemia
Sarcoma Granulocítico Cerebral na recorrência de Leucemia Mielóide Crônica
Angelo Borsarelli Carvalho Brito1, Fabiano Reis2, Ana Laura Gatti Palma2, Carmen Silvia Passos Lima1
A 21-year-old male with a 2-year diagnosis of chronic
myeloid leukemia in complete hematologic and cytogenetic
responses was admitted to hospital with drowsiness, head-
ache and seizures. Laboratory evaluation disclosed leucoci-
tosis with 19.0% of peripheral blasts. Brain magnetic
resonance imaging (MRI) (Figure 1) corroborated the dia-
gnosis of granulocytic sarcoma (GS) in blast crisis. MRI per-
formed 38 days after chemotherapy was indicative of tumor
regression (Figure 2).
GS is an extramedullary solid tumor composed of imma-
ture myeloid cells1. It develops before, during or after the
onset of myeloid leukemia2. Intra-axial GS without involve-
ment of skull or meninges is rare3.
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Figure 1. (A) Magnetic resonance imaging (MRI) shows an intra-axial right parietal solid lesion, isointense on T2 weighted image;
(B) With edema and mass effect seen on FLAIR; (C) MRI T1 weighted image post contrast shows a heterogeneous enhancement
hyperintense in (D) diffusion weighted imaging and (E) hypointense in ADC map, characterizing restricted diffusion.
Figure 2. Follow up magnetic resonance imaging after 38 days
of chemotherapy with methotrexate and cytosine arabinoside
shows significant reduction of the tumor and mass effect on
(A) T2 weighted image and (B) FLAIR; (C) ADC map shows areas
of high signal suggesting the cellularity of the tumor was
reduced over this period.
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